首页 | 本学科首页   官方微博 | 高级检索  
     

尿毒症患者透析前后纤溶系统的变化及其临床意义
引用本文:高国静,程翠玲,贾强,刘荣坤. 尿毒症患者透析前后纤溶系统的变化及其临床意义[J]. 首都医科大学学报, 2000, 21(3): 212-213
作者姓名:高国静  程翠玲  贾强  刘荣坤
作者单位:[1]首都医科大学宣武医院肾脏内科 [2]宣武医院心血管内科
摘    要:为探讨尿毒症患者纤溶系统的变化及透析对纤溶系统的影响 ,应用发色底物法和酶标法检测 2 0例尿毒症患者透析前后及对照组的纤溶酶原 (Plg)活性、组织性纤溶酶原激活剂 (t PA)活性、纤溶酶原激活剂抑制物 (PAI)活性及D 二聚体 (D D)定量。发现尿毒症患者较对照组t PA明显降低 (P <0 .0 1 ) ,D D有所降低 ,PAI及Plg有所升高 ,而尿毒症患者透析前后纤溶系统各项指标均无明显变化。提示尿毒症患者纤溶系统活性下降 ,此作用不受透析的影响

关 键 词:尿毒症  纤溶系统  透析
收稿时间:2000-04-18
修稿时间:2000-04-18

Clinical Significance and Variation of Fibrinolysis before and after Dialysis in Patients with Uremia
Gao Guojing,Cheng Cuiling,Jia Qiang,Liu Rongkun. Clinical Significance and Variation of Fibrinolysis before and after Dialysis in Patients with Uremia[J]. Journal of Capital Medical University, 2000, 21(3): 212-213
Authors:Gao Guojing  Cheng Cuiling  Jia Qiang  Liu Rongkun
Affiliation:1. Renal Department, Xuanwu Hospital, Affiliate of Capital University of Medical Sciences;2. Department of Cardiology, Xuanwu Hospital
Abstract:For investigating the variation of fibrinolysis in patients with uremia and the influence of dialysis on fibrnolysis, Plg, t PA, PAI and D D were examined in 20 patients with uremia and 13 healthy controls. It was found that t PA was sousiderably higher in patients with uremia than in controls ( P <0.01), D D decreased and PAI and Plg increased, and there were no any differences before and after dialysis in patients with uremia. It was suggested that variation of fibrinolysis in patients with uremia is not influenced by dialysis.
Keywords:uremia  fibrinolysis  dialysis
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《首都医科大学学报》浏览原始摘要信息
点击此处可从《首都医科大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号